Success Stories: NIW Granted for Cutting-Edge in Public Health
Client’s Testimonial:
“Thank you for the notice. It was very nice working with you!”
On February 24th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Ph.D. student in the Field of Public Health (Approval Notice).
General Field: Public Health
Position at the Time of Case Filing: PhD Student
Country of Origin: China
Approval Notice Date: February 24th, 2025
Processing Time: 2 months, 4 days (Premium Processing Requested)
Case Summary:
NAILG is proud to announce the approval of a National Interest Waiver (NIW) petition for a distinguished expert in public health whose work is driving advancements in U.S. healthcare. The client’s proposed endeavor focuses on utilizing advanced statistical analysis methods and software, as well as conducting collaborative medical research, to address some of the most pressing healthcare challenges in the United States. Her research directly targets healthcare disparity and precision medicine, aiming to enhance patient health nationwide.
By delivering cutting-edge data analysis on medical data, her work elevates patient outcomes and addresses global healthcare needs. Leveraging sophisticated statistical software, she advances the discovery of disease progression and fosters more equitable healthcare delivery. These efforts contribute to transformative solutions that bridge fundamental gaps in healthcare access and quality.
The client’s record of achievement reflects her leadership and expertise in the field:
- 31 peer-reviewed journal articles (including 1 first-authored) and 1 preprint.
- 315 total citations across her published works.
- 7 papers ranking among the top 10% most-cited articles for their year of publication.
- At least 50 peer reviews completed for respected journals in the medical and statistical sciences.
NAILG was honored to represent this biostatistics expert and prepare a compelling petition that emphasized the national importance and substantial merit of her work. This approval further affirms her potential to continue driving innovations that will benefit patients, researchers, and healthcare systems across the United States.

